The Asian Scientist 100
Di Li
Institution
National Astronomical Observatories of the Chinese Academy of Sciences
Country
China
Field
Aerospace & Astronomy
Li received the Marcel Grossmann Award for his pioneering contributions in the field of fast radio bursts. Li is the first scientist in China to receive this prize for research conducted within China.
(Photo: The Paper)
AWARDS
- Marcel Grossmann Award
Related articles
Changing the World, One Toilet at a Time
From loo-building projects to social enterprises and even smart toilets, World Toilet Organisation founder, Mr Jack Sim, turns to innovation to address a neglected public health crisis: poor sanitation.
Embracing The Contact Sport Of Innovation
To truly harness the power of personalized medicine, we had to bring our technology out of the lab and into the marketplace. Here’s how we did it with KYAN Therapeutics.
Polymers Make Pigment-Free Printing Possible
By exposing polymers to stress, scientists in Japan have developed a colour palette for printing which does not involve the use of pigments.
Removing Metals And Microbes From Water
A research group in Hong Kong has invented an inexpensive and efficient nanoporous membrane that can eliminate heavy metals and bacteria in water.
Two Steps Toward Green Fuels
An international team of researchers has developed a two-step method to break down carbohydrates, a crucial first step in producing green fuel.
Eczema Apps Inconsistent With Clinical Guidelines
A research team in Singapore has found that information in a third of eczema apps falls short of or does not agree with international guidelines.
Catalyst Converts CO2 Into Chemical Feedstock
Researchers in Japan have found an environmentally friendly path to reducing carbon dioxide levels while yielding industrially important formate products.
A Good BET On Liposarcoma Treatment
Scientists in Singapore have found that BET proteins play a huge role in the development of liposarcoma, making them a target for future anticancer drugs.
Setting Speed Limits On Financial Reporting & Clinical Trial Disclosures
Two studies on the financial and pharmaceutical industries highlight the protective role of regulations and the human cost when companies place self-interest over compliance.